STOCK TITAN

Director at ACHIEVE Life Sciences (ACHV) granted 47,250 stock options at $5.59

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

ACHIEVE LIFE SCIENCES, INC. director Martin Christopher Nathan received a grant of stock options covering 47,250 shares of Common Stock. The options have an exercise price of $5.59 per share and expire on May 11, 2036.

The award was provided as compensation and is held directly. According to the terms, the option will vest in substantially equal monthly installments over 36 months starting on May 11, 2026, as long as Nathan continues to provide service to the company on each vesting date.

Positive

  • None.

Negative

  • None.
Insider Martin Christopher Nathan
Role null
Type Security Shares Price Value
Grant/Award Stock Option (right to buy) 47,250 $0.00 --
Holdings After Transaction: Stock Option (right to buy) — 47,250 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Options granted 47,250 options Stock Option grant on May 11, 2026-related award
Exercise price $5.59 per share Exercise price for the 47,250-share option grant
Expiration date May 11, 2036 Option award expiration
Underlying shares 47,250 shares Common Stock underlying the option
Post-grant derivative holdings 47,250 options Total options following this transaction
Vesting schedule 36 monthly installments Vesting starts May 11, 2026, service-based
Stock Option financial
"Stock Option (right to buy)"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price": "5.5900""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date": "2036-05-11T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
Common Stock financial
"underlying_security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
vest financial
"The option will vest in substantially equal monthly installments over 36 months"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Martin Christopher Nathan

(Last)(First)(Middle)
22722 29TH DR. SE
SUITE 100

(Street)
BOTHELL WASHINGTON 98021

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ACHIEVE LIFE SCIENCES, INC. [ ACHV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/11/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$5.5905/11/2026A47,250 (1)05/11/2036Common Stock47,250$047,250D
Explanation of Responses:
1. The option will vest in substantially equal monthly installments over 36 months commencing May 11, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Sandra Thomson as attorney-in-fact for Chris Martin05/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did ACHV director Martin Christopher Nathan report in this Form 4?

Martin Christopher Nathan reported receiving a grant of stock options for 47,250 shares of ACHIEVE LIFE SCIENCES, INC. common stock. These options were awarded as compensation and are held directly, reflecting an acquisition of derivative securities rather than an open-market stock purchase.

What is the exercise price of the new ACHV stock options granted to the director?

The stock options granted to the director have an exercise price of $5.59 per share. This means he can purchase ACHIEVE LIFE SCIENCES, INC. common stock at $5.59 per share once the options vest, subject to the award’s service-based vesting conditions.

How many ACHV shares are covered by the stock options in this Form 4?

The option award covers 47,250 shares of ACHIEVE LIFE SCIENCES, INC. common stock. Following this grant, the total reported derivative holdings related to this award are 47,250 options, all subject to future vesting before they can be exercised for shares.

When do Martin Christopher Nathan’s ACHV options start vesting and over what period?

The options begin vesting on May 11, 2026 in substantially equal monthly installments. Vesting occurs over 36 months, and each monthly tranche requires that Nathan continue providing service to ACHIEVE LIFE SCIENCES, INC. on the relevant vesting date.

When do the newly granted ACHV stock options to the director expire?

The stock options granted to the director expire on May 11, 2036. After that expiration date, any unexercised portion of the 47,250-share option grant can no longer be used to purchase ACHIEVE LIFE SCIENCES, INC. common stock at the stated exercise price.

Is this ACHV Form 4 an open-market stock purchase or a compensation grant?

This Form 4 reflects a compensation-related stock option grant, not an open-market share purchase. The transaction code is “A,” indicating a grant or award, with 47,250 options issued at a $5.59 exercise price, subject to multi-year service-based vesting conditions.